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ers (CRS-1 and CRS-2) were investigated. Abnormal CRS-1 was defined as abnormal
PLF or abnormal TS only when PLF was not analysable. Abnormal CRS-2 was defined
as abnormal TS or abnormal PLF only when TS was not analysable. 
Results: There were 295 patients with LVEF < 30% in the placebo arm of EMIAT trial of
those 57 died during mean follow-up of 22 months. The mortality of 19.3% was compara-
ble to that in conventional-therapy group in MADIT II trial (19.8%). Prediction results are
shown in the Table. CRS-1 stratification associated with sensitivity of 49% would reduce
the costs of defibrillator therapy to 23%. CRS-2 stratification associated with sensitivity of
68% would reduce the costs of defibrillator therapy to 39%.
Conclusion: As MADIT II indication criteria for defibrillator therapy are not fully imple-
mented due to the lack of financial resources, the selection of patients at the highest risk
with acceptable sensitivity using Holter-based risk stratifiers might be of considerable
clinical value.
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Background: Although overt forms of ARVD are easily identified, it is difficult to differen-
tiate patients with a mild form of ARVD who have minimal involvement of the right ventri-
cle from those with idiopathic ventricular tachycardia (IVT). The aim of our study was to
identify electrocardiographic (ECG) criteria that best distinguish early ARVD from IVT.
Methods & Results: After excluding 19 patients with diffuse ARVD, the study population
consisted of 48 consecutive patients who presented with left bundle branch block (LBBB)
VT. Localized ARVD (n=20) was diagnosed based on the presence of regional RV
lesions, such as segmental RV wall motion abnormalities (hypo-akinetic or dyskinetic
areas), with mild or no ejection fraction reduction, whereas IVT (n=30) was classified
based on the exclusion of structural heart disease. Patients with localized ARVD com-
pared to IVT had a greater QRS duration in V1-V3 (113±14 vs.99±12 ms, p=0.0004), S
wave upstroke duration in V1-V3 (57±10 vs. 37±9 ms, p<0.0001), QRS dispersion (33±9
vs. 24±11 ms, p<0.02), and QT dispersion (67±18 vs. 37±14 ms, p<0.0001). The relative
prevalence of ECG abnormalities in these two conditions is shown in the table. An S
wave upstroke duration >55 ms in V1-V3 had the highest diagnostic value with a Chi-
square value of 36.7.
Conclusion: A delayed S wave upstroke in V1-V3 is the ECG parameter which best dif-
ferentiates mild ARVD from IVT, and might be considered as diagnostic ECG criteria for
ARVD.
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Background: T Wave Alternans (TWA) is a novel technique of risk stratification for sud-
den cardiac death. Exercise and atrial pacing have been studied with regards to their
influence on TWA. In the present study, we investigated the differential effect of atrial and
atrioventricular pacing on TWA outcome (TWA-O) and TWA magnitude (TWA-M) and
examined their correlation with outcome of standard electrophysiology study (EPS) in
patients with coronary disease and left ventricular dysfunction. 
Methods: Atrial and atrioventricular pacing at 5 rates (80, 90, 100, 110, 115 bpm) for 1.5
minutes was performed followed by EPS in 34 patients with a history of coronary disease
and mean ejection fraction 28% referred for risk stratification. A Cambridge Heart, Heart-
wave system was used to analyze TWA-O (+ or - ) according to standard guidelines.
TWA analysis was based on recordings from 6 precordial leads and 4 orthogonal leads.
Results: Atrioventricular pacing resulted in higher TWA-M when compared to atrial pac-
ing alone, but both sites yielded similar TWA-O (p=0.02; Sign Test; kappa=0.61). Mono-
morphic ventricular tachycardia was inducible in 20/34 patients. TWA was positive in 16
patients during atrial pacing and in 13 patients during atrioventricular pacing but TWA-O
did not correlate with EPS outcome. The ECG lead distribution of TWA was independent
of pacing site. Leads V2-V4 demonstrated 100% sensitivity for positive TWA
Conclusion: 1. Increased TWA-M during ventricular pacing suggests that ventricular
pacing may be proarrhythmic. 2. TWA and EPS measure different indices of electrical
instability and could be used in combination. 3. The use of the anterior precordial leads
may allow for a simplified approach in recording TWA. 4. Ventricular pacing may be alter-
native method to assess TWA in patients with atrial fibrillation. 
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Background:Episodes of transient ST-segment elevation (STe) on Holter monitoring has
been associated with increased mortality after ST-segment elevation myocardial infarc-
tion (STEMI). However, previous studies all antedate the advent of primary angioplasty
(PA).
We compared the prevalence and prognostic implications of STe, detected early after
STEMI treated with fibrinolysis or PA respectively.
Methods: Holter monitoring was initiated at discharge from STEMI in 951 patients who
had been randomized to immediate revascularization with either fibrinolysis (n = 473) or
PA (n = 478) as part of the DANAMI-2 study. Significant STe was defined as an upward
shift of the ST segment > 0.2 mV in magnitude that lasted > 1 minute. Follow-up ranged
from 2 to 5 years. Primary end point was all-cause mortality.
Results:In the fibrinolysis group 48 (10.1%) had STe as compared to 26 (5.4%) in the PA
group (p = 0.007). Mortality in the fibrinolysis group was significantly higher among
patients with STe (hazard ratio: 4.1; p < 0.0001), and in a stepwise multivariate Cox
regression analysis incorporating clinical and investigational variables, STe was indepen-
dently correlated to outcome (p < 0.001). In the PA group however, none of the patients
with STe on Holter monitoring died during follow-up.
Conclusion: Immediate revascularization with PA in STEMI reduces the incidence of
subsequent STe as compared to fibrinolysis. Furthermore, unlike in fibrinolysed patients,
STe is not associated with increased mortality after PA. 
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Background: Descriptors of QT/RR relationship were reported repeatedly to provide
information superior to simple QTc interval. We therefore investigated the exact profile of
QT adaptation to changes in RR interval in Holter recordings of patients from the EMIAT
database.
Methods: In 866 (462 amiodarone (A), 404 placebo (P)) 24-hour Holter recordings
obtained 1 month after randomisation into EMIAT RR, and QT intervals were measured
automatically on a beat-to-beat basis using a commercial Holter system. The individual
QT rate adaptation profile was assessed on a continuous basis quantifying the weighted
impact of RR interval history on each measured QT interval. The speed of adaptation
was assessed by the so-called lambda factor (LF). The smaller the LF, the faster the QT/
RR adaptation (figure). The values of the LF were compared between survivors and
Prediction of all-cause mortality using CRS-1 and CRS-2
 CRS-1  CRS-2
 abnormal  normal  abnormal  normal
non-survivors
(absolute numbers) 28 29 39  18
survivors (absolute numbers)
 41  197  75  163
sensitivity (%)
 49.1 68.4
positive predictive value (%)
40.6 34.2
ECG Characteristics of ARVD vs. Idiopathic Ventricular Tachycardia
Localized 
ARVD
n=20
Idiopathic 
VTn=28
P value Ch- Square 
value
T wave inversion V1-V3 and 
beyond
14 (70%) 0 (-) <0.0001 27.6
Epsilon wave 3 (15%) 0 (-) 0.03 3.8
QRS>110 V1-V3 ms 10 (50%) 0 (-) <0.0001 17.7
QRS V1+V2+V3/ QRSd 
V4+V5+V6>1.2
12 (60%) 2 (7%) <0.0001 15.7
QRS dispersion>40 ms 7 (35%) 1 (4%) 0.004 8.3
QT dispersion>65 ms 12 (60%) 3 (10%) <0.0001 8.3
S wave upstroke>55 V1-V3 ms 18 (90%) 1 (4%) <0.0001 36.7
